EUVIMEDEUVIMED entdecken
Crossref

Long-Term Durability of the Sorin Soprano Aortic Bioprosthetic Valve—A Swedish Nationwide Study

Gustav Hökfelt iD, Allan Clarelin, Magnus Höglund, Michael Dismorr iD, Shahab Nozohoor iD, Anders Jeppsson iD, Anna Damlin iD, Anders Franco-Cereceda iD, Ulrik Sartipy iD, Magnus Dalén iD

European Journal of Cardio-Thoracic Surgery · 2026

DOI: 10.1093/ejcts/ezaf469 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2026. Verfasst von Gustav Hökfelt und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Karolinska University Hospital, Stockholm SE-171 76, Sweden. Hauptthemen laut MEDLINE: Bioprosthesis, Heart Valve Prosthesis, Aortic Valve, Prosthesis Failure. Die Arbeit nennt 28 Literaturangaben. Gefördert von: The Schörling Foundation, Swedish Heart-Lung Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Structural valve deterioration is an inherent limitation of bioprosthetic valves; however, the time it takes to develop varies depending on the valve model. The Sorin Soprano aortic bioprosthetic valve (Sorin Group/LivaNova, Milan, Italy) lacks reported long-term results. This study aims to establish the long-term durability of this bioprosthetic valve in a nationwide cohort.

Methods

All patients who had received the Soprano bioprosthesis during aortic valve replacement in Sweden between 2005 and 2013 were included in the study. Patient characteristics, outcomes, and echocardiographic data were collected using national registries and electronic medical records. Standardized guidelines were used to assess echocardiographic data for the presence of severe structural valve deterioration.

Results

A total of 1054 patients (mean age 73.3 years) were included, with 14.0% being ≤65 years at surgery. The Soprano bioprosthesis represented 9.5% of all implanted bioprostheses. During a mean follow-up of 8.6 ± 4.5 years, 206 patients (19.5%) developed severe structural valve deterioration. The cumulative incidence of severe structural valve deterioration at 1, 5, 7, 10, and 15 years was 0.5%, 3.1%, 7.4%, 13.7%, and 22.1%, respectively, in the overall population. The cumulative incidence of structural valve deterioration-related reinterventions at 1, 5, 7, 10, and 15 years was 0%, 0.9%, 3.0%, 7.2%, and 11.5%, respectively. The 30-day mortality rate was 3.8%.

Conclusions

The Soprano bioprosthesis demonstrates high long-term rates of severe structural valve deterioration and deterioration-related reinterventions. These findings suggest the need for increased clinical vigilance and for more frequent echocardiographic monitoring in patients having received this bioprosthetic valve.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BioprosthesisHeart Valve ProsthesisAortic ValveProsthesis FailureHeart Valve Prosthesis ImplantationHumansMaleAgedFemaleSwedenMiddle AgedAged, 80 and overProsthesis DesignRegistriesRetrospective StudiesEchocardiographyFollow-Up StudiesAortic Valve Stenosis

Stichwörter der Autor:innen

aortic stenosisaortic valve replacementbioprosthesislong-term outcomesstructural valve deterioration

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery, Karolinska University Hospital, Stockholm SE-171 76, Sweden.
  • Department of Cardiothoracic and Vascular Surgery, Lund University and Skane University Hospital, Lund SE-221 85, Sweden.
  • Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg S-413 45, Sweden.
  • Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm SE-171 76, Sweden.
  • Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, Gothenburg S-413 45, Sweden.
  • Department of Cardiology, Karolinska University Hospital, Stockholm SE-171 76, Sweden.

ORCID-Profile: Gustav Hökfelt, Michael Dismorr, Shahab Nozohoor, Anders Jeppsson, Anna Damlin, Anders Franco-Cereceda, Ulrik Sartipy, Magnus Dalén

Förderung

  • The Schörling Foundation
  • Swedish Heart-Lung Foundation

Zitieren

APA

Hökfelt, G., Clarelin, A., Höglund, M., Dismorr, M., Nozohoor, S., Jeppsson, A., Damlin, A., Franco-Cereceda, A., Sartipy, U., & Dalén, M. (2026). Long-Term Durability of the Sorin Soprano Aortic Bioprosthetic Valve—A Swedish Nationwide Study. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf469

Vancouver

Hökfelt G, Clarelin A, Höglund M, Dismorr M, Nozohoor S, Jeppsson A, et al. Long-Term Durability of the Sorin Soprano Aortic Bioprosthetic Valve—A Swedish Nationwide Study. European Journal of Cardio-Thoracic Surgery. 2026. doi:10.1093/ejcts/ezaf469

BibTeX
@article{Hkfelt2026,
  author = {Hökfelt, Gustav and Clarelin, Allan and Höglund, Magnus and Dismorr, Michael and Nozohoor, Shahab and Jeppsson, Anders and Damlin, Anna and Franco-Cereceda, Anders and Sartipy, Ulrik and Dalén, Magnus},
  title = {Long-Term Durability of the Sorin Soprano Aortic Bioprosthetic Valve—A Swedish Nationwide Study},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2026},
  doi = {10.1093/ejcts/ezaf469}
}
Kostenlos starten →